Tuesday, 27 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14748
Articles
Company
Drug
BMS’s Abraxane Approved in China for First-Line Metastatic Pancreatic Cancer Treatment
November 13, 2024
Company
Deals
Bayer AG Leads Series D Investment in Jixing Pharmaceuticals, Eyeing Commercialization Rights
October 28, 2024
Policy / Regulatory
China’s NMPA Issues Guidelines for Inspection of Third-Party Online Drug Trading Platforms
October 28, 2024
Company
Deals
Novartis Strikes Deal with Argo Biopharma for Global Rights to siRNA Drug Candidates
October 28, 2024
Company
Deals
Novartis to Fully Acquire SanReno Therapeutics to Expand Kidney Drug Portfolio in China
October 28, 2024
Company
Drug
Jiangsu Hengrui Pharmaceuticals Wins NMPA Nod for SGLT-2 Inhibitor and Metformin Combo for Type 2 Diabetes
December 3, 2024
Company
Medical Device
MicroPort CardioFlow Medtech’s AnchorMan System Receives NMPA Approval as First Semi-Closed LAA Occluder in China
October 28, 2024
Company
Deals
Ningbo Linstant Polymer Materials Secures Over USD 14 Million in Series B Financing to Boost Production and Global Reach
October 28, 2024
Company
Deals
Lion TCR Partners with MaxCyte to Develop mRNA-Based TCR-T Therapies for Solid Tumors and Viral Diseases
October 28, 2024
Company
Deals
OnCusp Therapeutics Secures Oversubscribed USD 100 Million Series A Financing for CDH6-Targeting ADC
October 28, 2024
Company
Deals
Merck In-Licenses Inspirna’s Ompenaclid for Advanced Colorectal Cancer, Eyes Market Potential
October 28, 2024
Company
Deals
Boehringer Ingelheim Teams Up with 3T Biosciences for Next-Gen T-Cell Cancer Therapies
October 28, 2024
1
2
…
818
819
820
821
822
…
1,228
1,229
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?